Literature DB >> 11058759

alpha(1)-Microglobulin: a yellow-brown lipocalin.

B Akerström1, L Lögdberg, T Berggård, P Osmark, A Lindqvist.   

Abstract

alpha(1)-Microglobulin, also called protein HC, is a lipocalin with immunosuppressive properties. The protein has been found in a number of vertebrate species including frogs and fish. This review summarizes the present knowledge of its structure, biosynthesis, tissue distribution and immunoregulatory properties. alpha(1)-Microglobulin has a yellow-brown color and is size and charge heterogeneous. This is caused by an array of small chromophore prosthetic groups, attached to amino acid residues at the entrance of the lipocalin pocket. A gene in the lipocalin cluster encodes alpha(1)-microglobulin together with a Kunitz-type proteinase inhibitor, bikunin. The gene is translated into the alpha(1)-microglobulin-bikunin precursor, which is subsequently cleaved and the two proteins secreted to the blood separately. alpha(1)-Microglobulin is found in blood and in connective tissue in most organs. It is most abundant at interfaces between the cells of the body and the environment, such as in lungs, intestine, kidneys and placenta. alpha(1)-Microglobulin inhibits immunological functions of white blood cells in vitro, and its distribution is consistent with an anti-inflammatory and protective role in vivo.

Mesh:

Substances:

Year:  2000        PMID: 11058759     DOI: 10.1016/s0167-4838(00)00157-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.

Authors:  Vasantha Jotwani; Rebecca Scherzer; David V Glidden; Megha Mehrotra; Patricia Defechereux; Albert Liu; Monica Gandhi; Michael Bennett; Steven G Coca; Chirag R Parikh; Robert M Grant; Michael G Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

2.  Use of α1-microglobulin for diagnosing chronic interstitial nephropathy.

Authors:  Nicolas R Robles; Juan Lopez-Gomez; Guadalupe Garcia-Pino; Flavio Ferreira; Raul Alvarado; Emilio Sanchez-Casado; Juan J Cubero
Journal:  Clin Exp Med       Date:  2013-06-21       Impact factor: 3.984

3.  Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.

Authors:  Thomas A Rosenquist
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-23

4.  Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.

Authors:  M Park; R Katz; M G Shlipak; D Weiner; R Tracy; V Jotwani; J Hughes-Austin; F Gabbai; C Y Hsu; M Pfeffer; N Bansal; A Bostom; O Gutierrez; M Sarnak; A Levey; J H Ix
Journal:  Am J Transplant       Date:  2017-04-26       Impact factor: 8.086

5.  Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: a prospective cohort study.

Authors:  I Terzi; V Papaioannou; N Papanas; C Dragoumanis; A Petala; V Theodorou; T Gioka; V Vargemezis; E Maltezos; I Pneumatikos
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

6.  Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.

Authors:  Thorsten Berger; Atsushi Togawa; Gordon S Duncan; Andrew J Elia; Annick You-Ten; Andrew Wakeham; Hannah E H Fong; Carol C Cheung; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

7.  Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.

Authors:  Joachim H Ix; Ronit Katz; Nisha Bansal; Meredith Foster; Daniel E Weiner; Russell Tracy; Vasantha Jotwani; Jan Hughes-Austin; Dianne McKay; Francis Gabbai; Chi-Yuan Hsu; Andrew Bostom; Andrew S Levey; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2016-12-23       Impact factor: 8.860

8.  Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.

Authors:  Alexandra K Lee; Ronit Katz; Vasantha Jotwani; Pranav S Garimella; Walter T Ambrosius; Alfred K Cheung; Lisa H Gren; Javier A Neyra; Henry Punzi; Kalani L Raphael; Michael G Shlipak; Joachim H Ix
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

9.  HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.

Authors:  Vasantha Jotwani; Rebecca Scherzer; Michelle M Estrella; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Bernard Macatangay; Michael Bennett; Chirag R Parikh; Joachim H Ix; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2016-06-08       Impact factor: 8.860

10.  High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.

Authors:  Hao Huang; Yong Han; Jing Gao; Junnan Feng; Lei Zhu; Like Qu; Lin Shen; Chengchao Shou
Journal:  Med Oncol       Date:  2013-10-18       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.